Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering
NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) — New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented AV Therapeutics, Inc. (OTCQB:AVTH) on a $1.26 million private placement of units consisting of common stock and warrants at a unit price of $0.20. AV Therapeutics, Inc. is engaged in the business of developing cancer therapeutics and immunotherapeutic vaccines that can be used alone or in combination with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. The Sichenzia Ross Friedman Ference LLP team was led by partner Darrin M. Ocasio.
- Sichenzia Ross Ference LLP Represents A.G.P./ Alliance Global Partners as Placement Agent in $15M Registered Direct Offering of Arcimoto, Inc. - November 24, 2020
- Founding Partner Marc J. Ross, Esq. Quoted Regarding Cannabis SPACs Post U.S. Presidential Elections - November 23, 2020
- 2020 Income Tax Rates and Deductions - November 19, 2020